TrialJournal of diabetes investigation2022

Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials.

Daisuke Yabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.